BSX Q2 2019 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.6B+5.7% YoY

Gross Profit

$1.7B64.5% margin

Operating Income

$431M16.4% margin

Net Income

$154M5.9% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$292M

Free Cash Flow

$114M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$24.3B

Total Liabilities

$14.9B

Stockholders' Equity

$9.4B

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.6B	$2.5B	+5.7%
Gross Profit	$1.7B	$1.6B	+4.0%
Operating Income	$431M	$447M	-3.6%
Net Income	$154M	$555M	-72.3%

Revenue Segments

Cardiovascular

$1.0B56%

MedSurg

$818M44%

Geographic Segments

UNITED STATES

$1.5B56%

Non-US

$1.2B44%